Already on Thursday, stocks were giving back a chunk of Wednesday's historic gain. Goldman Sachs says the tariff pause likely won't stem declines. Goldman Sachs has raised its 12-month recession ...

Goldman Sachs downgraded contract research organizations Icon Public Limited (NASDAQ:ICLR) and Charles River Laboratories (NYSE:CRL) to Neutral from Buy on Friday, citing a challenging near-term ...

Half of the 46,000 employees at Goldman Sachs now have access to artificial intelligence. By the end of this year, chief information officer Marco Argenti expects even more will be able to tap ...

Goldman Sachs BDC cut its base dividend by 29% due to high non-accruals and decreased net investment income, impacting income-dependent investors. Despite the dividend cut, GSBD remains attractive ...

Charles River Laboratories International stock opened at $167.29 on Friday. The company’s fifty day simple moving average is $166.11 and its 200-day simple moving average is $183.66. The company ...

Lemkau spent nearly three decades at Goldman before departing in 2020 to become co-CEO of BDT & MSD Partners, an investment bank. Before his exit, he was widely seen as a top contender for CEO.

The US economy faces a growing risk of a recession as surging tariffs threaten to stunt growth, reignite inflation and lift unemployment, according to Goldman Sachs. The Wall Street bank warned ...

Fintel reports that on March 21, 2025, Goldman Sachs downgraded their outlook for Charles River Laboratories International (NYSE:CRL) from Buy to Neutral. Analyst Price Forecast Suggests 12.60% ...

NEW YORK, April 3 (Reuters) - Goldman Sachs (GS.N), opens new tab warned sweeping U.S. tariffs will weigh on global growth and prompt the Federal Reserve to cut interest rates more aggressively ...

Fintel reports that on March 21, 2025, Goldman Sachs downgraded their outlook for Charles River Laboratories International (BMV:CRL) from Buy to Neutral. Wellington Management Group Llp holds 4 ...